白藜芦醇减轻高原低压低氧大鼠心功能损伤的作用*

doi:10.12047/j.cjap.6384.2022.117

摘要/Abstract

摘要： 目的: 研究白藜芦醇(RSV)对高原低压低氧大鼠心功能的保护作用及机制。方法: 将36只大鼠按照随机数字法分为对照组(Control, C)、低压低氧组(HH)和低压低氧+RSV组(HH+RSV),每组12只。HH组和HH+RSV组大鼠在低压氧舱模拟海拔6 000 m,20 h / d进行慢性长期高原低压低氧干预8周,RSV灌喂浓度为400 mg/(kg·d)。大鼠每周检测1次体重、2次摄食量,大鼠处死前采用血细胞分析仪检测各组血常规指标、超声心动图检测各组大鼠心功能指标,采用HE染色评价心肌肥厚情况,采用二氢乙啶( DHE)染色评价心肌组织活性氧水平,采用血清及心肌组织总抗氧化能力(T-AOC)、超氧化物歧化酶活性(SOD)、丙二醛(MDA)含量评价氧化应激情况。结果: 与C组相比,HH组大鼠体质量和摄食量显著降低(P＜0.05);而与HH组相比,HH+RSV组大鼠体质量及摄食量无显著影响(P＞0.05)。血常规结果显示,与C组相比,HH组大鼠红细胞和血红蛋白显著升高(P＜0.05),血小板浓度显著降低(P＜0.05);与HH组相比,HH+RSV组大鼠红细胞和血红蛋白水平显著降低(P＜0.05),血小板浓度显著升高(P＜0.05)。与C组相比,HH组心脏系数、心肌纤维直径和厚度显著增大(P＜0.05);与HH组相比,HH+RSV组大鼠心脏系数和心肌纤维厚度显著下降(P＜0.05)。超声心动图分析显示,与C组相比,HH组大鼠心室壁厚度显著增加(P＜0.05),射血分数及心输出量显著降低(P＜0.05);与HH组相比,HH+RSV组大鼠心室壁厚度显著降低,心脏功能显著改善(P＜0.05)。DHE染色结果显示,与C组相比,HH组大鼠心肌组织活性氧水平显著升高(P＜0.05);与HH组相比,HH+RSV组大鼠心肌组织活性氧水平明显恢复(P＜0.05)。氧化抗氧化结果显示,与C组相比,HH组大鼠血清及心肌T-AOC、SOD活性显著降低(P＜0.05),MDA含量显著升高(P＜0.05);与HH组相比,HH+RSV组大鼠血清及心肌T-AOC、SOD活性显著升高(P＜0.05),MDA含量显著降低(P＜0.05)。结论: 长期高原低压低氧暴露导致大鼠心肌肥厚、心功能下降,白藜芦醇干预可以显著改善高原低压低氧暴露导致的大鼠心肌肥厚及心功能降低,这与其降低活性氧改善心肌氧化应激水平密切相关。

关键词: 低压低氧, 白藜芦醇, 心肌肥厚, 超声心动图, 大鼠

Abstract: Objective: To study the protective effects of resveratrol (RSV) on cardiac function in rats with high altitude hypobaric hypoxia and its mechanisms. Methods: Thirty-six rats were randomly divided into control group, hypobaric hypoxia group (HH) and hypobaric hypoxia + RSV group (HH+RSV) according to the random number, 12 rats in each group. Rats in the HH and HH+RSV groups were subjected to chronic long-term high altitude hypobaric hypoxia intervention for 8 weeks in a hypobaric chamber at a simulated altitude of 6 000 m for 20 h / d. The rats of HH + RSV were fed with RSV at a dose of 400 mg/(kg·d). The rats were tested once a week for body weight and twice a week for food intake. Before execution, the rats were tested by blood cell analyzer for routine blood parameters and echocardiogram for cardiac function parameters in each group. The routine blood indexes of each group were measured by blood cell analyzer, the cardiac function indexes of each group were measured by echocardiography, myocardial hypertrophy was evaluated by HE staining, myocardial tissue reactive oxygen levels were evaluated by dihydroethidium (DHE) staining. Oxidative stress was evaluated by serum and myocardial tissue total antioxidant capacity (T-AOC), superoxide dismutase activity (SOD) and malondialdehyde (MDA) content. Results: Compared with the C group, the body mass and food intake of rats were decreased significantly (P＜0.05) in HH group, while compared with the C group, RSV had no significant effects on the body mass and food intake of rats in the HH+RSV group (P＞0.05). Compared with the C group, the levels of erythrocytes and hemoglobin of rats in the HH group were increased significantly (P＜0.05), while the platelet concentration was decreased significantly(P＜0.05); compared with the HH group, the erythrocyte and hemoglobin levels were decreased significantly (P＜0.05) and platelet concentration was increased significantly(P＜0.05) in rats of the HH+RSV group. Compared with the C group, the cardiac coefficient, myocardial fiber diameter and thickness were significantly increased in the HH group (P＜0.05); compared with the HH group, the cardiac coefficient and myocardial fiber thickness were significantly decreased in the HH+RSV group (P＜0.05). Echocardiographic analysis showed a significant increase in ventricular wall thickness (P＜0.05) and a significant decrease in ejection fraction and cardiac output (P＜0.05) in the HH group compared with the C group, and a significant decrease in ventricular wall thickness and a significant improvement in cardiac function (P＜0.05) in the HH+RSV group compared with the HH group. The results of DHE staining showed that myocardial tissue reactive oxygen levels were increased significantly in the HH group compared with the C group (P＜0.05); myocardial tissue reactive oxygen levels were significantly restored in the HH+RSV group compared with the HH group (P＜0.05). The oxidative/antioxidant results showed that the serum and myocardial T-AOC and SOD activities were decreased significantly (P＜0.05) and the MDA level was increased significantly (P＜0.05) in the HH group compared with the C group; the serum and myocardial T-AOC and SOD activities were increased significantly (P＜0.05) and the MDA level was decreased significantly(P＜0.05) in the HH+RSV group compared with the HH group. Conclusion: Long-term plateau hypobaric hypoxia exposure leads to myocardial hypertrophy and reduced cardiac function in rats. Resveratrol intervention significantly improves myocardial hypertrophy and cardiac function in rats caused by altitude hypobaric hypoxia exposure, which is closely related to reducing of reactive oxygen species and improving myocardial oxidative stress levels.

Key words: hypobaric hypoxia, Resveratrol, myocardial hypertrophy, echocardiography, rats

中图分类号:

R361.2

徐洪宝, 宋晓娜, 闫长青, 王光瑞, 蒲玲玲, 王紫瑈, 王新兴, 陈照立, 刘伟丽. 白藜芦醇减轻高原低压低氧大鼠心功能损伤的作用^*[J]. 中国应用生理学杂志, 2022, 38(6): 644-649.

XU Hong-bao, SONG Xiao-na, YAN Chang-qing, WANG Guang-rui, PU Ling-ling, WANG Zi-rou, WANG Xin-xing, CHEN Zhao-li, LIU Wei-li. Resveratrol attenuates cardiac function impairment in plateau hypobaric hypoxia rats[J]. CJAP, 2022, 38(6): 644-649.

参考文献

[1] Bilo G, Caravita S, Torlasco C, et al. Blood pressure at high altitude: physiology and clinical implications[J]. Kardiol Pol, 2019, 77(6): 596-603.
[2] Lorell B, Apstein C, Weinberg E, et al. Diastolic function in left ventricular hypertrophy: clinical and experimental relationships[J]. Eur Heart J, 1990, 11(Suppl G): 54-64.
[3] Tasatargil A, Tanriover G, Barutcigil A, et al. Protective effect of resveratrol on methylglyoxal-induced endothelial dysfunction in aged rats[J]. Aging Clin Exp Res, 2019, 31(3): 331-338.
[4] Xu D, Li Y, Zhang B, et al. Resveratrol alleviate hypoxic pulmonary hypertension via anti-inflammation and anti-oxidant pathways in rats[J]. Int J Med Sci, 2016, 13(12): 942-954.
[5] Chung J, Manganiello V, Dyck J. Resveratrol as a calorie restriction mimetic: therapeutic implications[J]. Trends Cell Biol, 2012, 22(10): 546-554.
[6] Yan C, Wang Z, Liu W et al. Resveratrol ameliorates high altitude hypoxia-induced osteoporosis by suppressing the ROS/HIF signaling pathway[J]. Mol, 2022, 27(17): 538-546.
[7] Genovese A, Alfieri W, Latte S, et al. Regression of myocardial hypertrophy in the rat following removal of acute or chronic hypobaric hypoxia[J]. Eur Heart J, 1982, 3(Suppl A): 161-164.
[8] Flores K, Siques P, Brito J, et al. Lower body weight in rats under hypobaric hypoxia exposure would lead to reduced right ventricular hypertrophy and increased AMPK activation[J]. Front Physiol, 2020, 11: 342-360.
[9] LI Y, Zhou Y, Zhang D, et al. Hypobaric hypoxia regulates iron metabolism in rats[J]. J Cell biochem, 2019, 120(8): 14076-14087.
[10] Siques P, Brito J, Flores K, et al. Long-term chronic intermittent hypobaric hypoxia induces glucose transporter (GLUT4) translocation through AMP-activated protein kinase (AMPK) in the soleus muscle in lean rats[J]. Front Physiol, 2018, 9: 799-813.
[11] Deng B, Liu W, Pu L, et al. Quantitative proteomics reveals the effects of resveratrol on high-altitude polycythemia treatment[J]. Prote, 2020, 20(14): 1335-1346.
[12] Ooi J, Bernardo B, Mcmullen J. The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy[J]. Future Med Chem, 2014, 6(2): 205-222.
[13] Dolinsky V, Soltys C, Rogan K, et al. Resveratrol prevents pathological but not physiological cardiac hypertrophy[J]. J Mol Med (Berl), 2015 , 93(4): 413-425.
[14] Xie S, Deng Y, Pan Y, et al. Melatonin protects against chronic intermittent hypoxia-induced cardiac hypertrophy by modulating autophagy through the 5' adenosine monophosphate-activated protein kinase pathway[J]. Biochem Biophys Res Commun, 2015, 464(4): 975-981.
[15] Truong V, Jun M, Jeong W. Role of resveratrol in regulation of cellular defense systems against oxidative stress[J]. Bio Factors, 2018, 44(1): 36-49.
[16] Zhang X, Zhang X, Xv J, et al. Crocin attenuates acute hypobaric hypoxia-induced cognitive deficits of rats[J]. Eur J Pharmacol, 2018, 818: 300-305.
[17] Han Y, Jo H, Cho J, et al. Resveratrol as a tumor-suppressive nutraceutical modulating tumor microenvironment and malignant behaviors of cancer[J]. Int J Mol Sci, 2019, 20(4): 925-942.
[18] Wang H, Feng H, Zhang Y. Resveratrol inhibits hypoxia-induced glioma cell migration and invasion by the p-STAT3/miR-34a axis[J]. Neoplasma, 2016, 63(4): 532-539.

白藜芦醇减轻高原低压低氧大鼠心功能损伤的作用^*

Resveratrol attenuates cardiac function impairment in plateau hypobaric hypoxia rats

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李畅, 范荣, 李东波, 周威, 黄玉娥, 王斌. 促红细胞生成素衍生肽(HBSP)对大鼠急性骨骼肌拉伤诱发肾损伤的干预作用^*[J]. 中国应用生理学杂志, 2022, 38(6): 617-621.
[2]	刘璇, 聂慧鹏, 刘焕亮, 石玥, 来文庆, 袭著革, 林本成. 上皮间质转化在油雾颗粒物诱导心肌纤维化中的作用^*[J]. 中国应用生理学杂志, 2022, 38(6): 633-637.
[3]	冯静茹, 张海洋, 史贺, 王腾飞, 王紫监, 程光慧, 毕胜利. 雌二醇对大鼠心肌缺血/再灌注损伤的干预作用及其机制^*[J]. 中国应用生理学杂志, 2022, 38(6): 638-643.
[4]	宋正阳, 王新雨, 田云娜, 李卓伦, 王肖婷, 袁琳波, 王万铁. 三七总皂苷对肺动脉高压大鼠肺血管重构的影响及其机制^*[J]. 中国应用生理学杂志, 2022, 38(6): 650-654.
[5]	王洪瑾, 李毅, 冯艳萍, 张科伟, 彭毛东智. 红景天苷对慢性低氧后冻伤大鼠血管内皮细胞的保护作用^*[J]. 中国应用生理学杂志, 2022, 38(6): 664-669.
[6]	廖忠鑫, 黄蕾, 朱洪竹, 朱梅菊. KLF15/mTOR相关蛋白在有氧间歇性运动改善2型糖尿病大鼠骨骼肌病变中的作用^*[J]. 中国应用生理学杂志, 2022, 38(6): 676-681.
[7]	刘乃红, 王佃卿, 彭志锋. 荷包牡丹碱联合早期跑步运动对大鼠脑损伤恢复的协同效应^*[J]. 中国应用生理学杂志, 2022, 38(6): 700-703.
[8]	吴卫东, 王宇, 魏建翔. MICT/HIIT对高脂膳食大鼠心肌和比目鱼肌超微结构的影响及机制探讨^*[J]. 中国应用生理学杂志, 2022, 38(6): 708-713.
[9]	夏岩石, 高虹, 赵丹威. 力竭运动对大鼠凝血状态的影响^*[J]. 中国应用生理学杂志, 2022, 38(6): 714-718.
[10]	吕莹盈, 高巧婧, 张金梅, 李雪, 金毓, 王璐. 线粒体自噬对有氧运动干预大鼠抑郁的作用^*[J]. 中国应用生理学杂志, 2022, 38(6): 719-724.
[11]	张亚萍, 田蕾, 谢晓倩, 王亚婷, 吕鹏, 袭著革. 妊娠期纳米聚苯乙烯纳米塑料暴露对胎鼠发育及神经毒性研究^*[J]. 中国应用生理学杂志, 2022, 38(6): 760-765.
[12]	储文彬, 丁天琪, 文波, 陆俊宇, 樊嵘, 陈学伟. 氢对高蛋氨酸饮食诱导的高同型半胱氨酸血症和脂肪肝的缓解作用^*[J]. 中国应用生理学杂志, 2022, 38(6): 787-792.
[13]	毕小波, 张霞, 文继鹏, 丁委, 李进. 反复七氟烷暴露对新生大鼠海马细胞凋亡和远期学习记忆能力的影响^*[J]. 中国应用生理学杂志, 2022, 38(6): 807-813.
[14]	张凯, 马敬霞, 马作旺, 杨禹, 李广平. 慢性间歇低氧对SD大鼠心房电重构的影响^*[J]. 中国应用生理学杂志, 2022, 38(5): 385-391.
[15]	潘存瑶, 张宝怡, 梁兰兰, 刘辉, 郭长江, 陈照立, 王新兴. 三种多酚类化合物对模拟间断性高原低氧暴露小鼠肠道菌群的影响^*[J]. 中国应用生理学杂志, 2022, 38(5): 392-396.